This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Hypersensitivity  • Dermatologic Disorders, Other  • Drug Therapy  • Adverse Effects  • Allergy  • Alert me on articles by topic

Antoine Amado, MD; James S. Taylor, MD; Debora A. Murray, LPN; Jeffrey S. Reynolds, BS

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

According to the package insert, MimyX Cream (Stiefel Laboratories Inc, Coral Gables, Florida) is a "fragrance-free, preservative-free, water-based emulsion formulated for the management and relief of the burning and itching experienced with various types of dermatoses, including atopic dermatitis, allergic contact dermatitis and radiation dermatitis."¹ The MimyX Cream package label lists the following ingredients: purified water, olive oil, glycerin, pentylene glycol (PTG), palm glycerides, vegetable oil, hydrogenated lecithin, squalane, betaine, palmitamide monoethanolamine (PEA), sarcosine, acetamide monoethanolamine, hydroxyethyl cellulose, sodium carbomer, carbomer, and xanthan gum.¹ The PEA is an endogenous bioactive fatty acid that is deficient in atopic skin and is reported to be replenished by MimyX Cream.² The cream is also said to restore the disrupted skin barrier characteristic of atopic dermatitis.²

Report of a Case

A 44-year-old woman with atopic dermatitis presented with a 20-year history of hand . . . [Full Text of this Article]

Comment

AUTHOR INFORMATION